Literature DB >> 16942018

Design, synthesis, and biophysical and biological evaluation of a series of pyrrolobenzodiazepine-poly(N-methylpyrrole) conjugates.

Geoff Wells1, Christopher R H Martin, Philip W Howard, Zara A Sands, Charles A Laughton, Arnaud Tiberghien, Chi Kit Woo, Luke A Masterson, Marissa J Stephenson, John A Hartley, Terence C Jenkins, Steven D Shnyder, Paul M Loadman, Michael J Waring, David E Thurston.   

Abstract

A novel series of methyl ester-terminated C8-linked pyrrolobenzodiazepine (PBD)-poly(N-methylpyrrole) conjugates (50a-f) has been synthesized and their DNA interaction evaluated by thermal denaturation, DNA footprinting, and in vitro transcription stop assays. The synergistic effect of attaching a PBD unit to a polypyrrole fragment is illustrated by the large increase in DNA binding affinity (up to 50-fold) compared to the individual PBD and pyrrole components. 50a-f were found to bind mainly to identical DNA sequences but with apparent binding site widths increasing with molecular length and the majority of sites conforming to the consensus motif 5'-XGXWz (z = 3 +/- 1; W = A or T; X = any base but preferably a purine). They also provided robust sequence-selective blockade of transcription at sites corresponding approximately to their DNA footprints. 50a-f were shown to have good cellular/nuclear penetration properties, and a degree of correlation between cytotoxicity and DNA-binding affinity was observed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16942018     DOI: 10.1021/jm051199z

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  16 in total

1.  Design and Synthesis of Tesirine, a Clinical Antibody-Drug Conjugate Pyrrolobenzodiazepine Dimer Payload.

Authors:  Arnaud C Tiberghien; Jean-Noel Levy; Luke A Masterson; Neki V Patel; Lauren R Adams; Simon Corbett; David G Williams; John A Hartley; Philip W Howard
Journal:  ACS Med Chem Lett       Date:  2016-05-24       Impact factor: 4.345

2.  DNA Sequence Preference and Adduct Orientation of Pyrrolo[2,1-c][1,4]benzodiazepine Antitumor Agents.

Authors:  Khondaker M Rahman; Higia Vassoler; Colin H James; David E Thurston
Journal:  ACS Med Chem Lett       Date:  2010-08-13       Impact factor: 4.345

3.  Design and characterization of homogenous antibody-drug conjugates with a drug-to-antibody ratio of one prepared using an engineered antibody and a dual-maleimide pyrrolobenzodiazepine dimer.

Authors:  Jason B White; Ryan Fleming; Luke Masterson; Ben T Ruddle; Haihong Zhong; Christine Fazenbaker; Patrick Strout; Kim Rosenthal; Molly Reed; Vanessa Muniz-Medina; Philip Howard; Rakesh Dixit; Herren Wu; Mary Jane Hinrichs; Changshou Gao; Nazzareno Dimasi
Journal:  MAbs       Date:  2019-03-05       Impact factor: 5.857

4.  Modulation of topoisomerase IIα expression and chemosensitivity through targeted inhibition of NF-Y:DNA binding by a diamino p-anisyl-benzimidazole (Hx) polyamide.

Authors:  Luke Pett; Konstantinos Kiakos; Vijay Satam; Pravin Patil; Sarah Laughlin-Toth; Matthew Gregory; Michael Bowerman; Kevin Olson; Mia Savagian; Megan Lee; Moses Lee; W David Wilson; Daniel Hochhauser; John A Hartley
Journal:  Biochim Biophys Acta Gene Regul Mech       Date:  2016-10-24       Impact factor: 4.490

5.  Biosynthesis, Mechanism of Action, and Inhibition of the Enterotoxin Tilimycin Produced by the Opportunistic Pathogen Klebsiella oxytoca.

Authors:  Evan M Alexander; Dale F Kreitler; Valeria Guidolin; Alexander K Hurben; Eric Drake; Peter W Villalta; Silvia Balbo; Andrew M Gulick; Courtney C Aldrich
Journal:  ACS Infect Dis       Date:  2020-06-24       Impact factor: 5.084

6.  Design and Synthesis of Isoquinolidinobenzodiazepine Dimers, a Novel Class of Antibody-Drug Conjugate Payload.

Authors:  Sean W Smith; Vasu Jammalamadaka; Dmitry Borkin; Jianyu Zhu; Sylvia J Degrado; Jennifer Lu; Jianqing Huang; Ying-Ping Jiang; Nareshkumar Jain; Jagath R Junutula
Journal:  ACS Med Chem Lett       Date:  2017-12-06       Impact factor: 4.345

7.  DNA sequence-selective C8-linked pyrrolobenzodiazepine-heterocyclic polyamide conjugates show anti-tubercular-specific activities.

Authors:  Federico Brucoli; Juan D Guzman; Mohammad A Basher; Dimitrios Evangelopoulos; Eleanor McMahon; Tulika Munshi; Timothy D McHugh; Keith R Fox; Sanjib Bhakta
Journal:  J Antibiot (Tokyo)       Date:  2016-05-11       Impact factor: 2.649

8.  Effect of base sequence on the DNA cross-linking properties of pyrrolobenzodiazepine (PBD) dimers.

Authors:  Khondaker M Rahman; Colin H James; David E Thurston
Journal:  Nucleic Acids Res       Date:  2011-03-21       Impact factor: 16.971

9.  Antistaphylococcal activity of DNA-interactive pyrrolobenzodiazepine (PBD) dimers and PBD-biaryl conjugates.

Authors:  Khondaker M Rahman; Helena Rosado; Joao B Moreira; Eva-Anne Feuerbaum; Keith R Fox; Eva Stecher; Philip W Howard; Stephen J Gregson; Colin H James; Maria de la Fuente; Denise E Waldron; David E Thurston; Peter W Taylor
Journal:  J Antimicrob Chemother       Date:  2012-04-30       Impact factor: 5.790

10.  The minor groove-binding agent ELB-21 forms multiple interstrand and intrastrand covalent cross-links with duplex DNA and displays potent bactericidal activity against methicillin-resistant Staphylococcus aureus.

Authors:  Helena Rosado; Khondaker M Rahman; Eva-Anne Feuerbaum; Jason Hinds; David E Thurston; Peter W Taylor
Journal:  J Antimicrob Chemother       Date:  2011-03-03       Impact factor: 5.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.